taurocholic acid has been researched along with furosemide in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cha, SH; Endou, H; Kanai, Y; Kojima, R; Kusuhara, H; Sekine, T; Sugiyama, Y; Tsuda, M; Utsunomiya-Tate, N | 1 |
| Cvetkovic, M; Kim, RB; Leake, B; Nadeau, J; Roden, MM; Walubo, A; Wilkinson, GR | 1 |
| Cha, SH; Endou, H; Fukushima , JI; Goya, T; Kanai, Y; Kobayashi, Y; Sekine, T | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Barlow, JW; Lim, CF; Raggatt, LE; Stockigt, JR; Topliss, DJ | 1 |
| Ballatori, N; Truong, AT | 1 |
| Deutscher, J; Föllmann, W; Kinne, RK; Müller, N; Petzinger, E | 1 |
| Bear, CE; Ilson, RG; Strasberg, SM | 1 |
| Anwer, MS; Clayton, LM | 1 |
| Blitzer, BL; Boyer, JL; Donovan, CB; Ratoosh, SL | 1 |
| Afifi, F | 1 |
| Gordon, S; Müllertz, A; Nielsen, LH; Pajander, JP; Rades, T; Østergaard, J | 1 |
1 review(s) available for taurocholic acid and furosemide
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
14 other study(ies) available for taurocholic acid and furosemide
| Article | Year |
|---|---|
Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain.
Topics: Amino Acid Sequence; Animals; Brain; Carrier Proteins; Cloning, Molecular; DNA, Complementary; Estrone; Molecular Sequence Data; Ochratoxins; Organic Anion Transporters, Sodium-Independent; p-Aminohippuric Acid; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequence Homology, Amino Acid; Xenopus laevis | 1999 |
Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity.
Topics: Bile Acids and Salts; Biological Transport, Active; Carrier Proteins; Cells, Cultured; HeLa Cells; Humans; Kinetics; Liver; Nicotine; Organic Anion Transporters, Sodium-Dependent; Plasmids; RNA, Messenger; Salicylates; Symporters; Vaccinia virus; Valproic Acid | 1999 |
Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney.
Topics: Amino Acid Sequence; Animals; Carrier Proteins; Chromosome Mapping; Chromosomes, Human, Pair 11; Cloning, Molecular; Gene Library; Humans; Kidney Tubules, Proximal; Molecular Sequence Data; Oocytes; Organic Anion Transporters, Sodium-Independent; Sequence Homology, Amino Acid; Tissue Distribution; Transfection; Xenopus laevis | 2001 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Characterization of cytoplasmic T3 binding sites by adsorption to hydroxyapatite: effects of drug inhibitors of T3 and relationship to glutathione-S-transferases.
Topics: Amiodarone; Animals; Binding Sites; Binding, Competitive; Cytosol; Diclofenac; Dithiothreitol; Dose-Response Relationship, Drug; Durapatite; Furosemide; Glutathione Transferase; Hydrocortisone; Hydroxyapatites; In Vitro Techniques; Iopanoic Acid; Liver; Macaca fascicularis; Mefenamic Acid; Sulfobromophthalein; Taurocholic Acid; Triiodothyronine | 1992 |
Relation between biliary glutathione excretion and bile acid-independent bile flow.
Topics: Aminopyrine; Animals; Arsenic; Arsenites; Benzylamines; Bile; Bile Acids and Salts; Buthionine Sulfoximine; Cefamandole; Furosemide; Glutathione; Glycocholic Acid; Kinetics; L-Lactate Dehydrogenase; Liver; Male; Methionine Sulfoximine; Nitrofurantoin; Phenobarbital; Rats; Rats, Inbred Strains; Sodium Compounds; Taurocholic Acid | 1989 |
Uptake of bumetanide into isolated rat hepatocytes and primary liver cell cultures.
Topics: Affinity Labels; Animals; Bile Acids and Salts; Binding, Competitive; Biological Transport, Active; Bumetanide; Carrier Proteins; Cells, Cultured; Chromatography, Thin Layer; Diuretics; Furosemide; Kinetics; Liver; Male; Photochemistry; Rats; Rats, Inbred Strains; Sodium; Taurocholic Acid; Temperature | 1989 |
Bile salt dependent bile flow in the rabbit: evidence for the importance of an amiloride inhibitable pathway.
Topics: Amiloride; Animals; Bile; Bile Acids and Salts; Biliary Tract; Erythritol; Furosemide; Glycodeoxycholic Acid; Male; Rabbits; Taurocholic Acid | 1986 |
Role of extracellular Ca2+ in hepatic bile formation and taurocholate transport.
Topics: Animals; Bile; Bile Acids and Salts; Bumetanide; Calcium; Cell Membrane Permeability; Furosemide; Inulin; Liver; Membrane Potentials; Oxygen Consumption; Rats; Taurocholic Acid | 1985 |
Effects of inhibitors of Na+-coupled ion transport on bile acid uptake by isolated rat hepatocytes.
Topics: Animals; Biological Transport; Bumetanide; Diuretics; Furosemide; Kinetics; Liver; Male; Rats; Rats, Inbred Strains; Sodium; Sodium-Potassium-Exchanging ATPase; Taurocholic Acid | 1982 |
Choleretic action of furosemide in dogs: effect of bilateral ligation of renal pedicles.
Topics: Animals; Bile; Dogs; Furosemide; Kidney; Potassium; Sodium; Taurocholic Acid | 1982 |
Biorelevant characterisation of amorphous furosemide salt exhibits conversion to a furosemide hydrate during dissolution.
Topics: Acids; Chemistry, Pharmaceutical; Crystallization; Furosemide; Hydrogen-Ion Concentration; Intestinal Secretions; Phosphatidylcholines; Salts; Solubility; Taurocholic Acid | 2013 |